483 Chongqing Pharmaceutical Research Institute Nov 2017

483 Chongqing Pharmaceutical Research Institute Nov 2017

Peter Baker FDA, Christopher Middendorf FDA$119.00 - Available Now

FDA investigators audited the Chongqing Pharmaceutical Research Institute - Zhongqing, China facility and issued inspectional observations (via FDA 483) on 30 Nov 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 30 Nov 2017
  • Location: Zhongqing, China
  • FEI: 3011903543
Add To Cart